Symbol:
Prkd3
Name:
protein kinase D3
RGD ID:
1310236
Description:
Predicted to enable protein serine/threonine kinase activity. Predicted to be involved in intracellular signal transduction and phospholipase C-activating G protein-coupled receptor signaling pathway. Predicted to be located in ciliary basal body; nucleoplasm; and plasma membrane. Predicted to be active in cytosol. Orthologous to human PRKD3 (protein kinase D3); INTERACTS WITH (+)-schisandrin B; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC313834; Prkcn; protein kinase C, nu; serine/threonine-protein kinase D3
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
PRKD3 (protein kinase D3)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Prkd3 (protein kinase D3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Prkd3 (protein kinase D3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
PRKD3 (protein kinase D3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
PRKD3 (protein kinase D3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Prkd3 (protein kinase D3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
PRKD3 (protein kinase D3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
PRKD3 (protein kinase D3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Prkd3 (protein kinase D3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
TRIM34 (tripartite motif containing 34)
HGNC
OMA
Alliance orthologs 3
Mus musculus (house mouse):
Prkd3 (protein kinase D3)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
PRKD3 (protein kinase D3)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
prkd3 (protein kinase D3)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
PKD
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
dkf-2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 6 21,784,665 - 21,860,600 (+) NCBI GRCr8 mRatBN7.2 6 16,032,507 - 16,108,444 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 6 16,032,585 - 16,108,443 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 6 16,355,379 - 16,423,921 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 6 16,677,588 - 16,746,130 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 6 16,157,980 - 16,226,554 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 6 1,546,018 - 1,622,232 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 6 1,548,415 - 1,622,196 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 6 1,536,128 - 1,611,876 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 6 1,727,315 - 1,796,290 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 6 1,751,738 - 1,764,473 (-) NCBI Celera 6 15,704,621 - 15,773,170 (+) NCBI Celera Cytogenetic Map 6 q12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Prkd3 Rat (+)-catechin multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of PRKD3 mRNA CTD PMID:24763279 Prkd3 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKD3 mRNA] CTD PMID:31150632 Prkd3 Rat (1->4)-beta-D-glucan multiple interactions ISO Prkd3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRKD3 mRNA CTD PMID:36331819 Prkd3 Rat 1,2-dimethylhydrazine multiple interactions ISO Prkd3 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PRKD3 mRNA CTD PMID:22206623 Prkd3 Rat 1,2-dimethylhydrazine affects expression ISO Prkd3 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of PRKD3 mRNA CTD PMID:22206623 Prkd3 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of PRKD3 mRNA CTD PMID:32145629 Prkd3 Rat 17beta-estradiol increases expression ISO Prkd3 (Mus musculus) 6480464 Estradiol results in increased expression of PRKD3 mRNA CTD PMID:39298647 Prkd3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKD3 mRNA CTD PMID:18796159 more ... Prkd3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Prkd3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PRKD3 mRNA CTD PMID:21570461 Prkd3 Rat 3-methylcholanthrene decreases expression ISO Prkd3 (Mus musculus) 6480464 Methylcholanthrene results in decreased expression of PRKD3 mRNA CTD PMID:20713471 Prkd3 Rat 4,4'-diaminodiphenylmethane increases expression ISO Prkd3 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of PRKD3 mRNA CTD PMID:18648102 Prkd3 Rat 4,4'-sulfonyldiphenol affects expression ISO Prkd3 (Mus musculus) 6480464 bisphenol S affects the expression of PRKD3 mRNA CTD PMID:39298647 Prkd3 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PRKD3 mRNA CTD PMID:24780913 Prkd3 Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of PRKD3 mRNA CTD PMID:28959563 Prkd3 Rat all-trans-retinoic acid decreases expression ISO PRKD3 (Homo sapiens) 6480464 Tretinoin results in decreased expression of PRKD3 mRNA CTD PMID:33167477 Prkd3 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of PRKD3 mRNA CTD PMID:30779732 Prkd3 Rat aristolochic acid A decreases expression ISO PRKD3 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of PRKD3 mRNA CTD PMID:33212167 Prkd3 Rat Aroclor 1254 decreases expression ISO Prkd3 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of PRKD3 mRNA CTD PMID:23650126 Prkd3 Rat arsane increases response to substance ISO PRKD3 (Homo sapiens) 6480464 PRKD3 mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 Prkd3 Rat arsane multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRKD3 mRNA CTD PMID:39836092 Prkd3 Rat arsenic atom increases response to substance ISO PRKD3 (Homo sapiens) 6480464 PRKD3 mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 Prkd3 Rat arsenic atom multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRKD3 mRNA CTD PMID:39836092 Prkd3 Rat arsenous acid increases expression ISO PRKD3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of PRKD3 mRNA CTD PMID:20458559 Prkd3 Rat benzo[a]pyrene decreases expression ISO PRKD3 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of PRKD3 mRNA CTD PMID:20064835 Prkd3 Rat benzo[a]pyrene increases methylation ISO Prkd3 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of PRKD3 3' UTR more ... CTD PMID:27901495 Prkd3 Rat benzo[a]pyrene increases methylation ISO PRKD3 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of PRKD3 promoter CTD PMID:27901495 Prkd3 Rat benzo[a]pyrene increases expression ISO Prkd3 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of PRKD3 mRNA CTD PMID:22228805 Prkd3 Rat benzo[a]pyrene decreases expression ISO Prkd3 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of PRKD3 mRNA CTD PMID:19770486 Prkd3 Rat benzo[a]pyrene diol epoxide I decreases expression ISO PRKD3 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Prkd3 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PRKD3 mRNA CTD PMID:25181051 Prkd3 Rat bisphenol A multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PRKD3 gene CTD PMID:31601247 Prkd3 Rat bisphenol A increases expression ISO Prkd3 (Mus musculus) 6480464 bisphenol A results in increased expression of PRKD3 mRNA CTD PMID:33221593 Prkd3 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PRKD3 mRNA CTD PMID:32145629 Prkd3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRKD3 mRNA CTD PMID:30816183 and PMID:32528016 Prkd3 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PRKD3 mRNA CTD PMID:31129395 Prkd3 Rat carbamazepine affects expression ISO PRKD3 (Homo sapiens) 6480464 Carbamazepine affects the expression of PRKD3 mRNA CTD PMID:24752500 Prkd3 Rat carbon nanotube decreases expression ISO Prkd3 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Prkd3 Rat chenodeoxycholic acid multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PRKD3 mRNA more ... CTD PMID:33819548 Prkd3 Rat chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of PRKD3 mRNA CTD PMID:17452286 Prkd3 Rat chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of PRKD3 mRNA CTD PMID:19368821 Prkd3 Rat ciguatoxin CTX1B affects expression ISO Prkd3 (Mus musculus) 6480464 Ciguatoxins affects the expression of PRKD3 mRNA CTD PMID:18353800 Prkd3 Rat cisplatin increases expression ISO PRKD3 (Homo sapiens) 6480464 Cisplatin results in increased expression of PRKD3 mRNA CTD PMID:27594783 Prkd3 Rat clofibrate decreases expression ISO Prkd3 (Mus musculus) 6480464 Clofibrate results in decreased expression of PRKD3 mRNA CTD PMID:23811191 Prkd3 Rat clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PRKD3 mRNA CTD PMID:17602206 Prkd3 Rat cobalt dichloride decreases expression ISO PRKD3 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of PRKD3 mRNA CTD PMID:19320972 Prkd3 Rat coumarin increases phosphorylation ISO PRKD3 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of PRKD3 protein CTD PMID:35688186 Prkd3 Rat crocidolite asbestos decreases expression ISO Prkd3 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of PRKD3 mRNA CTD PMID:29279043 Prkd3 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PRKD3 mRNA CTD PMID:26577399 Prkd3 Rat decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of PRKD3 mRNA CTD PMID:23914054 Prkd3 Rat deoxycholic acid multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PRKD3 mRNA more ... CTD PMID:33819548 Prkd3 Rat diarsenic trioxide increases expression ISO PRKD3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of PRKD3 mRNA CTD PMID:20458559 Prkd3 Rat diazinon affects expression EXP 6480464 Diazinon affects the expression of PRKD3 mRNA CTD PMID:17452286 Prkd3 Rat diclofenac affects expression ISO PRKD3 (Homo sapiens) 6480464 Diclofenac affects the expression of PRKD3 mRNA CTD PMID:24752500 Prkd3 Rat dicrotophos decreases expression ISO PRKD3 (Homo sapiens) 6480464 dicrotophos results in decreased expression of PRKD3 mRNA CTD PMID:28302478 Prkd3 Rat diquat decreases expression ISO Prkd3 (Mus musculus) 6480464 Diquat results in decreased expression of PRKD3 mRNA CTD PMID:36851058 Prkd3 Rat doxorubicin decreases expression ISO PRKD3 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of PRKD3 mRNA CTD PMID:29803840 Prkd3 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PRKD3 mRNA CTD PMID:29391264 Prkd3 Rat ethanol increases expression EXP 6480464 Ethanol results in increased expression of PRKD3 mRNA CTD PMID:20655511 Prkd3 Rat ethanol increases expression ISO Prkd3 (Mus musculus) 6480464 Ethanol results in increased expression of PRKD3 mRNA CTD PMID:30319688 Prkd3 Rat fipronil increases expression EXP 6480464 fipronil results in increased expression of PRKD3 mRNA CTD PMID:34044035 Prkd3 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PRKD3 mRNA CTD PMID:24136188 and PMID:24793618 Prkd3 Rat folic acid multiple interactions ISO Prkd3 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PRKD3 mRNA CTD PMID:22206623 Prkd3 Rat folic acid decreases expression ISO PRKD3 (Homo sapiens) 6480464 Folic Acid results in decreased expression of PRKD3 mRNA CTD PMID:21867686 Prkd3 Rat fulvestrant multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PRKD3 gene CTD PMID:31601247 Prkd3 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PRKD3 mRNA CTD PMID:22061828 Prkd3 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PRKD3 mRNA CTD PMID:33387578 Prkd3 Rat glycochenodeoxycholic acid multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PRKD3 mRNA more ... CTD PMID:33819548 Prkd3 Rat glycocholic acid multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PRKD3 mRNA more ... CTD PMID:33819548 Prkd3 Rat glycodeoxycholic acid multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PRKD3 mRNA more ... CTD PMID:33819548 Prkd3 Rat hexadecanoic acid decreases phosphorylation ISO PRKD3 (Homo sapiens) 6480464 Palmitic Acid results in decreased phosphorylation of PRKD3 protein CTD PMID:28073184 Prkd3 Rat ivermectin decreases expression ISO PRKD3 (Homo sapiens) 6480464 Ivermectin results in decreased expression of PRKD3 protein CTD PMID:32959892 Prkd3 Rat lipopolysaccharide multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [IL4 protein co-treated with IL13 protein] inhibits the reaction [Lipopolysaccharides results in decreased expression of PRKD3 protein] CTD PMID:37182445 Prkd3 Rat lipopolysaccharide decreases expression ISO PRKD3 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of PRKD3 protein CTD PMID:37182445 Prkd3 Rat methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PRKD3 mRNA CTD PMID:30467583 Prkd3 Rat microcystin-LR increases expression ISO Prkd3 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of PRKD3 mRNA CTD PMID:17383702 Prkd3 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PRKD3 mRNA CTD PMID:17602206 Prkd3 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKD3 mRNA CTD PMID:25729387 Prkd3 Rat ozone decreases expression EXP 6480464 Ozone results in decreased expression of PRKD3 mRNA CTD PMID:35737395 Prkd3 Rat paracetamol affects expression ISO Prkd3 (Mus musculus) 6480464 Acetaminophen affects the expression of PRKD3 mRNA CTD PMID:17562736 Prkd3 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PRKD3 mRNA CTD PMID:33387578 Prkd3 Rat paracetamol multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of PRKD3 mRNA CTD PMID:33819548 Prkd3 Rat paracetamol decreases expression ISO PRKD3 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PRKD3 mRNA CTD PMID:21420995 Prkd3 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Prkd3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRKD3 mRNA CTD PMID:36331819 Prkd3 Rat phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of PRKD3 mRNA CTD PMID:19162173 Prkd3 Rat phenobarbital decreases expression ISO Prkd3 (Mus musculus) 6480464 Phenobarbital results in decreased expression of PRKD3 mRNA CTD PMID:23091169 Prkd3 Rat phlorizin decreases expression ISO Prkd3 (Mus musculus) 6480464 Phlorhizin results in decreased expression of PRKD3 mRNA CTD PMID:22538082 Prkd3 Rat pirinixic acid decreases expression ISO Prkd3 (Mus musculus) 6480464 pirinixic acid results in decreased expression of PRKD3 mRNA CTD PMID:18445702 more ... Prkd3 Rat pregnenolone 16alpha-carbonitrile decreases expression ISO Prkd3 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of PRKD3 mRNA CTD PMID:28903501 Prkd3 Rat propiconazole decreases expression ISO Prkd3 (Mus musculus) 6480464 propiconazole results in decreased expression of PRKD3 mRNA CTD PMID:21278054 Prkd3 Rat quercetin decreases expression ISO PRKD3 (Homo sapiens) 6480464 Quercetin results in decreased expression of PRKD3 mRNA CTD PMID:21632981 Prkd3 Rat resveratrol multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PRKD3 mRNA CTD PMID:23557933 Prkd3 Rat rimonabant multiple interactions ISO Prkd3 (Mus musculus) 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of PRKD3 mRNA] CTD PMID:19030233 Prkd3 Rat rimonabant affects expression ISO Prkd3 (Mus musculus) 6480464 Rimonabant affects the expression of PRKD3 mRNA CTD PMID:19030233 Prkd3 Rat silicon dioxide decreases expression ISO Prkd3 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of PRKD3 mRNA CTD PMID:23221170 Prkd3 Rat sodium arsenate increases expression ISO Prkd3 (Mus musculus) 6480464 sodium arsenate results in increased expression of PRKD3 mRNA CTD PMID:21795629 Prkd3 Rat sodium arsenite multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRKD3 mRNA CTD PMID:39836092 Prkd3 Rat sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of PRKD3 mRNA CTD PMID:35314868 Prkd3 Rat sunitinib decreases expression ISO PRKD3 (Homo sapiens) 6480464 Sunitinib results in decreased expression of PRKD3 mRNA CTD PMID:31533062 Prkd3 Rat Sunset Yellow FCF multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PRKD3 mRNA CTD PMID:33819548 Prkd3 Rat tamoxifen affects expression ISO Prkd3 (Mus musculus) 6480464 Tamoxifen affects the expression of PRKD3 mRNA CTD PMID:20937368 Prkd3 Rat tartrazine multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PRKD3 mRNA CTD PMID:33819548 Prkd3 Rat testosterone increases expression ISO Prkd3 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of PRKD3 mRNA CTD PMID:33848595 Prkd3 Rat testosterone multiple interactions ISO Prkd3 (Mus musculus) 6480464 1 more ... CTD PMID:33848595 Prkd3 Rat tetrachloromethane affects expression ISO Prkd3 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of PRKD3 mRNA CTD PMID:17484886 Prkd3 Rat tetrachloromethane decreases expression ISO Prkd3 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of PRKD3 mRNA CTD PMID:31919559 Prkd3 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKD3 mRNA] CTD PMID:31150632 Prkd3 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PRKD3 mRNA CTD PMID:31150632 Prkd3 Rat thimerosal increases expression ISO PRKD3 (Homo sapiens) 6480464 Thimerosal results in increased expression of PRKD3 mRNA CTD PMID:27188386 Prkd3 Rat titanium dioxide decreases methylation ISO Prkd3 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of PRKD3 promoter CTD PMID:35295148 Prkd3 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKD3 mRNA CTD PMID:25729387 Prkd3 Rat tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PRKD3 mRNA CTD PMID:31129395 Prkd3 Rat trichostatin A increases expression ISO PRKD3 (Homo sapiens) 6480464 trichostatin A results in increased expression of PRKD3 mRNA CTD PMID:24935251 Prkd3 Rat triclosan multiple interactions ISO PRKD3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in increased expression of PRKD3 mRNA CTD PMID:33819548 Prkd3 Rat triphenyl phosphate affects expression ISO PRKD3 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of PRKD3 mRNA CTD PMID:37042841 Prkd3 Rat troglitazone decreases expression ISO Prkd3 (Mus musculus) 6480464 troglitazone results in decreased expression of PRKD3 mRNA CTD PMID:28973697 Prkd3 Rat valproic acid decreases expression ISO Prkd3 (Mus musculus) 6480464 Valproic Acid results in decreased expression of PRKD3 mRNA CTD PMID:21427059 Prkd3 Rat valproic acid affects expression ISO PRKD3 (Homo sapiens) 6480464 Valproic Acid affects the expression of PRKD3 mRNA CTD PMID:25979313 Prkd3 Rat valproic acid decreases methylation ISO PRKD3 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of PRKD3 gene CTD PMID:29154799 Prkd3 Rat valproic acid decreases expression ISO PRKD3 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of PRKD3 mRNA CTD PMID:23179753 more ...
(+)-catechin (ISO) (+)-schisandrin B (EXP) (1->4)-beta-D-glucan (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP,ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 3-methylcholanthrene (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 6-propyl-2-thiouracil (EXP) acrylamide (EXP) all-trans-retinoic acid (ISO) amphetamine (EXP) aristolochic acid A (ISO) Aroclor 1254 (ISO) arsane (ISO) arsenic atom (ISO) arsenous acid (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bisphenol A (EXP,ISO) carbamazepine (ISO) carbon nanotube (ISO) chenodeoxycholic acid (ISO) chlorpyrifos (EXP) ciguatoxin CTX1B (ISO) cisplatin (ISO) clofibrate (ISO) clofibric acid (EXP) cobalt dichloride (ISO) coumarin (ISO) crocidolite asbestos (ISO) Cuprizon (EXP) decabromodiphenyl ether (EXP) deoxycholic acid (ISO) diarsenic trioxide (ISO) diazinon (EXP) diclofenac (ISO) dicrotophos (ISO) diquat (ISO) doxorubicin (ISO) endosulfan (EXP) ethanol (EXP,ISO) fipronil (EXP) flutamide (EXP) folic acid (ISO) fulvestrant (ISO) gentamycin (EXP) glycochenodeoxycholic acid (ISO) glycocholic acid (ISO) glycodeoxycholic acid (ISO) hexadecanoic acid (ISO) ivermectin (ISO) lipopolysaccharide (ISO) methapyrilene (EXP) microcystin-LR (ISO) N-nitrosodiethylamine (EXP) oxaliplatin (EXP) ozone (EXP) paracetamol (EXP,ISO) perfluorooctane-1-sulfonic acid (ISO) phenobarbital (EXP,ISO) phlorizin (ISO) pirinixic acid (ISO) pregnenolone 16alpha-carbonitrile (ISO) propiconazole (ISO) quercetin (ISO) resveratrol (ISO) rimonabant (ISO) silicon dioxide (ISO) sodium arsenate (ISO) sodium arsenite (EXP,ISO) sunitinib (ISO) Sunset Yellow FCF (ISO) tamoxifen (ISO) tartrazine (ISO) testosterone (ISO) tetrachloromethane (EXP,ISO) thimerosal (ISO) titanium dioxide (ISO) topotecan (EXP) tributylstannane (EXP) trichostatin A (ISO) triclosan (ISO) triphenyl phosphate (ISO) troglitazone (ISO) valproic acid (ISO)
Prkd3 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 6 21,784,665 - 21,860,600 (+) NCBI GRCr8 mRatBN7.2 6 16,032,507 - 16,108,444 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 6 16,032,585 - 16,108,443 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 6 16,355,379 - 16,423,921 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 6 16,677,588 - 16,746,130 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 6 16,157,980 - 16,226,554 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 6 1,546,018 - 1,622,232 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 6 1,548,415 - 1,622,196 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 6 1,536,128 - 1,611,876 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 6 1,727,315 - 1,796,290 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 6 1,751,738 - 1,764,473 (-) NCBI Celera 6 15,704,621 - 15,773,170 (+) NCBI Celera Cytogenetic Map 6 q12 NCBI
PRKD3 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 2 37,250,502 - 37,324,833 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 2 37,250,502 - 37,324,833 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 2 37,477,645 - 37,551,976 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 2 37,331,149 - 37,397,726 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 2 37,389,298 - 37,455,873 NCBI Celera 2 37,318,598 - 37,385,166 (-) NCBI Celera Cytogenetic Map 2 p22.2 NCBI HuRef 2 37,217,514 - 37,283,993 (-) NCBI HuRef CHM1_1 2 37,407,074 - 37,473,671 (-) NCBI CHM1_1 T2T-CHM13v2.0 2 37,257,518 - 37,331,821 (-) NCBI T2T-CHM13v2.0
Prkd3 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 17 79,256,834 - 79,328,245 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 17 79,256,834 - 79,328,245 (-) Ensembl GRCm39 Ensembl GRCm38 17 78,949,405 - 79,020,816 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 17 78,949,405 - 79,020,816 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 17 79,348,745 - 79,420,156 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 17 78,855,607 - 78,918,364 (-) NCBI MGSCv36 mm8 Celera 17 83,270,085 - 83,333,948 (-) NCBI Celera Cytogenetic Map 17 E3 NCBI cM Map 17 49.69 NCBI
Prkd3 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955441 5,051,079 - 5,112,799 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955441 5,051,079 - 5,112,791 (-) NCBI ChiLan1.0 ChiLan1.0
PRKD3 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 12 89,154,788 - 89,229,111 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 2A 89,158,772 - 89,233,086 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 2A 37,278,043 - 37,352,364 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 2A 38,042,771 - 38,116,394 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 2A 38,042,771 - 38,116,394 (-) Ensembl panpan1.1 panPan2
PRKD3 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 17 29,607,484 - 29,696,304 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 17 29,610,159 - 29,687,550 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 17 29,421,475 - 29,510,291 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 17 30,257,459 - 30,346,099 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 17 30,258,830 - 30,346,080 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 17 29,484,730 - 29,573,085 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 17 29,548,330 - 29,639,287 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 17 29,766,130 - 29,854,593 (-) NCBI UU_Cfam_GSD_1.0
Prkd3 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024406292 42,313,646 - 42,382,136 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936663 979,130 - 1,049,427 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936663 979,136 - 1,047,633 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
PRKD3 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 3 102,842,229 - 102,941,329 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 3 102,840,666 - 102,949,128 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 3 109,438,196 - 109,546,779 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
PRKD3 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 14 70,064,678 - 70,142,790 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 14 70,072,330 - 70,140,176 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666045 41,805,140 - 41,881,579 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Prkd3 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 393 Count of miRNA genes: 227 Interacting mature miRNAs: 271 Transcripts: ENSRNOT00000007492 Prediction methods: Microtar, Miranda Result types: miRGate_prediction
8552962 Pigfal16 Plasma insulin-like growth factor 1 level QTL 16 9.4 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 6 1 41223769 Rat 1549905 Stresp10 Stress response QTL 10 6.83 0.0066 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 6 1 27574569 Rat 8693699 Alc37 Alcohol consumption QTL 37 2.6 0.224 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 6 7964167 21301982 Rat 10401812 Kidm54 Kidney mass QTL 54 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 6 14368788 59368788 Rat 1331743 Uae28 Urinary albumin excretion QTL 28 4.5 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 6 1 34235784 Rat 10401800 Kidm49 Kidney mass QTL 49 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 6 14368788 59368788 Rat 1300164 Rf15 Renal function QTL 15 3.12 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 6 5074497 54641141 Rat 9589129 Insul24 Insulin level QTL 24 19.06 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 6 1 41223769 Rat 1578758 Tcas9 Tongue tumor susceptibility QTL 9 3.29 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 6 1 37618905 Rat 4145119 Mcs25 Mammary carcinoma susceptibility QTL 25 0.0001 mammary gland integrity trait (VT:0010552) ratio of deaths to total study population during a period of time (CMO:0001023) 6 10894415 110548006 Rat 7411603 Foco13 Food consumption QTL 13 5.5 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 6 1 41223769 Rat 1598843 Cm63 Cardiac mass QTL 63 2.6 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 6 1 39036266 Rat 738024 Sach5 Saccharine consumption QTL 5 3.9 0.00039 consumption behavior trait (VT:0002069) saccharin intake volume to total fluid intake volume ratio (CMO:0001601) 6 1 43394190 Rat 7411542 Bw127 Body weight QTL 127 5.5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 6 1 41223769 Rat 2293706 Bmd20 Bone mineral density QTL 20 4.3 0.0002 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 6 5074497 19988050 Rat 9589048 Scfw3 Subcutaneous fat weight QTL 3 4.57 0.001 subcutaneous adipose mass (VT:1000472) abdominal subcutaneous fat pad weight (CMO:0002069) 6 1 41223769 Rat 2292616 Ept15 Estrogen-induced pituitary tumorigenesis QTL 15 4.4 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 6 9843312 20338915 Rat 738023 Alc17 Alcohol consumption QTL 17 3.1 0.003 consumption behavior trait (VT:0002069) ethanol drink intake rate to body weight ratio (CMO:0001616) 6 1 27574569 Rat 1354616 Despr12 Despair related QTL 12 0.0012 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 6 1 27574569 Rat 1576309 Emca7 Estrogen-induced mammary cancer QTL 7 4 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 6 15107216 107351382 Rat 2293709 Bss23 Bone structure and strength QTL 23 5.18 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 6 1 42487980 Rat 2293650 Bss31 Bone structure and strength QTL 31 5.05 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 6 1 42487980 Rat 7411584 Foco4 Food consumption QTL 4 4.3 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 6 1 42838846 Rat 1578665 Bss16 Bone structure and strength QTL 16 4.4 femur morphology trait (VT:0000559) bone trabecular cross-sectional area (CMO:0002311) 6 11735669 72593685 Rat 2300176 Bmd51 Bone mineral density QTL 51 11.7 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 6 1 27574569 Rat 1300128 Rf16 Renal function QTL 16 3.89 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 6 5074497 34434305 Rat 1578668 Bmd14 Bone mineral density QTL 14 3.8 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 6 11735669 72593685 Rat 2301972 Bp325 Blood pressure QTL 325 4.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 6 1 72227641 Rat 2293656 Bss28 Bone structure and strength QTL 28 6.79 0.0001 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 6 1 42487980 Rat 1358190 Ept1 Estrogen-induced pituitary tumorigenesis QTL 1 4.4 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 6 9843312 20338915 Rat 2300190 Bmd52 Bone mineral density QTL 52 11.2 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 6 1 27574569 Rat 8693690 Alc35 Alcohol consumption QTL 35 2.2 0.606 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 6 7964167 21301982 Rat
RH129843
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 6 16,108,080 - 16,108,260 (-) MAPPER mRatBN7.2 Rnor_6.0 6 1,546,202 - 1,546,381 NCBI Rnor6.0 Rnor_5.0 6 1,536,311 - 1,536,490 UniSTS Rnor5.0 RGSC_v3.4 6 1,727,498 - 1,727,677 UniSTS RGSC3.4 Celera 6 15,772,808 - 15,772,987 UniSTS Cytogenetic Map 6 q11 UniSTS
RH131273
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 6 16,108,645 - 16,108,825 (-) MAPPER mRatBN7.2 Rnor_6.0 6 1,545,637 - 1,545,816 NCBI Rnor6.0 Rnor_5.0 6 1,535,746 - 1,535,925 UniSTS Rnor5.0 RGSC_v3.4 6 1,726,933 - 1,727,112 UniSTS RGSC3.4 Celera 6 15,773,373 - 15,773,552 UniSTS RH 3.4 Map 6 32.8 UniSTS Cytogenetic Map 6 q11 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000007492 ⟹ ENSRNOP00000007491
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 6 16,039,896 - 16,108,443 (+) Ensembl Rnor_6.0 Ensembl 6 1,548,415 - 1,622,196 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000084528 ⟹ ENSRNOP00000069846
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 6 16,071,139 - 16,083,871 (+) Ensembl Rnor_6.0 Ensembl 6 1,570,683 - 1,583,417 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000095865 ⟹ ENSRNOP00000079860
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 6 16,044,022 - 16,108,443 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000101507 ⟹ ENSRNOP00000077406
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 6 16,032,585 - 16,041,481 (+) Ensembl
RefSeq Acc Id:
NM_001024263 ⟹ NP_001019434
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 21,792,052 - 21,860,600 (+) NCBI mRatBN7.2 6 16,039,896 - 16,108,443 (+) NCBI Rnor_6.0 6 1,546,019 - 1,614,851 (-) NCBI Rnor_5.0 6 1,536,128 - 1,611,876 (-) NCBI RGSC_v3.4 6 1,727,315 - 1,796,290 (-) RGD Celera 6 15,704,621 - 15,773,170 (+) RGD
Sequence:
TTTTCTCTCTGGGTCCATTCATCCAAAGAAATATGTTTGTGCTATTTGACAAGCTTTTTGTTTTCACCTCATCACAGGGAAGTTCAGCCACAAGATGGAAATGAGTACAGATGAGAGGGTGAATTAAG GTGTGATCATTTGTGGTGTCCCGTCAATCCCTAAAGGAATAGATTACCTGGAACTACTTTTAATCAGGAAGATTTCATATCTTGGCACAGATTGACTATTCAATTTGTATTTTCTGAAATGCAAAGCA AAAGATAAGAACAGATTTAAAAGAAATGAAGATGTCGCATAAATAATCAGTATCAACTCTGTTCCTTTGATGATAATGGTGATGTGAAGTGGGTTACAGATCTGGGTGTGGTCCTAAAGACAAGATTC TTGATGGGACTGACATTGACAGCAGTAGGACCTTTTGTGCATTCAACTCGGAGCAACAGAATTTGTCATCAACAGCATGAGTGGCTCAGCCAGGGAAAGAAAGCAGCTTTCATCTAAATCCAAACCAT AGCCATTTTTTTTTACTGCTATTTTGAAAACTTTTCCAGAACCATTTAAAAAGCATTGACAACTATTTTTATAGATTAAAGAAAGGCAGATGTCTGCAAATAATTCCCCTCCATCAGCCCAGAAATCT GTGTTCCCTGCAACTGTTTCTGCTGTGCTTCCAACCCCTTCTCCGTGTTCAAGTCCCAAGACAGGACTCTCAGCTCGGCTCTCTAATGGCAGCTTCAGTGCCGCGTCACTCACAAACTCTAGAGGCTC GGTGCACACCGTTTCATTTCTACTTCAGATTGGCCTCACACGAGAGAGTGTTACCATCGAAGCCCAGGAACTGTCTCTCTCCGCTGTCAAAGACCTCGTGTGCTCCATTGTTTATCAGAAGTTTCCAG AGTGTGGATTCTTTGGCATGTATGATAAAATTCTTCTCTTTCGCCACAACATGAACTCAGAAAACATTTTGCAGCTGATTACCTCAGCAGATGAAATACATGAAGGGGATCTTGTAGAAGTTGTCCTG TCAGCTTTGGCCACAGTAGAAGACTTCCAGATCCGCCCTCATGCTCTCTATGTCCATTCTTACAAAGCACCTACTTTCTGTGATTACTGTGGTGAAATGCTCTGGGGATTGGTACGTCAAGGATTAAA ATGTGAAGGCTGTGGATTAAATTATCATAAACGATGTGCCTTCAAGATTCCAAATAACTGCAGTGGAGTAAGAAAGAGACGTCTGTCAAATGTGTCTCTGCCAGGACCTGGCCTCTCAGTTCCGAGAC CCCTGCAGCCTGAATGTGTGCCCCTGCTCAGTGAAGAGTCACATACTCACCAAGAGCCAAGTAAGAGAATCCCGTCCTGGAGTGGTCGTCCGATCTGGATGGAAAAGATGGTAATGTGCAGGGTCAAA GTTCCACACACGTTTGCTGTCCACTCTTATGGCCGACCCACAATATGTCAGTACTGCAAGCGGCTGCTCAAAGGCCTCTTTCGCCAAGGACTGCAGTGTAAAGATTGCAAATTCAACTGCCACAAACG CTGTGCATCCAAAGTACCACGAGACTGCCTCGGCGAAGTTACTTTCAATGGAGAGCCTTCCAGTGTGGGAACTGATACAGACATGCCGATGGATATTGACAGTAATGATGTGAACAGTGATGGCAGTA GGGGCTTGGATGACTCAGAGGAGCCCTCCCCTCCCGAAGACAAAATGTTCTTCCTCGACGCGGCCGATCTGGATGTGGAGCGAGATGAGGAGCCGGTTAAGACAATCAGTCCATCCACAAGCAATAAT ATCCCACTGATGAGGGTGGTCCAGTCCATCAAGCACACAAAGAGGAAGAGCAGCACAGTGGTGAAGGAAGGGTGGATGGTCCACTACACCAGCAGGGACAACCTGAGAAAGAGACATTATTGGAGACT TGACAGCAAATGTCTAACATTGTTTCAGAATGAATCTGGATCAAAATATTATAAGGAAATTCCACTTTCAGAAATTCTCCGCATATCTTCGCCACAAGATTTCACCAGCATTTCACAAGGCAGTAACC CACACTGTTTTGAAATCATCACTGATACTGTGGTATACTTTGTTGGTGAGAACAATGGGAACAGCACTCATAACCCTGTTCTCGCTGCCACTGGAGTGGGACTCGATGTAGCACAAAGCTGGGAAAAA GCGATCCGCCAGGCCCTCATGCCCGTTACTCCTCAAGCAAGTGTTTGCACTTCTCCAGGCCAGGGGAAGGACCACAAAGATCTGGCTACCAGTATCTCCGTGTCTAACTGTCAGATTCAGGAGAATGT AGACATCAGCAGTGTTTATCAGATCTTTGCCGATGAGGTGCTTGGTTCTGGCCAGTTTGGCATTGTTTATGGAGGAAAGCACAGAAAGACAGGAAGGGATGTGGCTATTAAAGTAATCGATAAGATGC GATTCCCCACAAAGCAAGAGAGTCAGCTCCGGAATGAAGTGGCTATTTTACAGAATCTGCACCATCCTGGGATTGTAAATCTGGAATGTATGTTTGAAACCCCAGAACGAGTCTTCGTAGTGATGGAA AAGCTTCATGGAGATATGTTGGAAATGATTCTGTCCAGTGAAAAAAGTCGACTTCCAGAACGGATTACTAAATTCATGGTCACACAGATACTTGTTGCCCTGAGGAATCTACATTTTAAGAATATCGT GCACTGTGATTTAAAGCCCGAAAATGTGCTGCTTGCATCTGCAGAACCTTTTCCTCAGGTGAAGCTATGTGACTTTGGGTTTGCCCGCATCATTGGTGAGAAGTCGTTCCGGAGGTCAGTGGTGGGAA CTCCAGCCTACTTAGCCCCCGAGGTTCTCAGGAGCAAAGGCTACAACCGTTCCCTAGACATGTGGTCGGTGGGAGTCATAGTCTATGTGAGCCTCAGTGGCACCTTCCCGTTCAATGAAGATGAAGAT ATAAACGACCAAATCCAAAATGCTGCATTTATGTACCCACCAAATCCATGGCGAGAAATCTCCAGCGAAGCAATTGATTTGATAAACAACTTGCTTCAAGTGAAGATGAGAAAACGTTACAGCGTTGA CAAGTCCCTCAGTCATCCCTGGCTACAGGACTATCAGACTTGGCTTGACCTCAGAGAATTCGAAACTCGCATTGGAGAACGTTACATCACACATGAAAGTGATGATGCTCGCTGGGAAATACATGCAT ACACGCACAATCTCGAATACCCAAAACATTTCATTATGGCCCCCAACCCGGATGACATGGAGGAAGGTCCTTAGTTGTGAGTGGGCTAATCCTATAAGGAAGGGTTTCATTTCAAGACGGATACTTTG CTGCATGACTGTTGCTCTCTGCAGACTGTCATTGCAAGGCGGCAGCATCATGAGGACATAGAAGGACGTGCTGGCATCAATTCTGTAGCTCATAACGAGTAGGTACATGAAGGGAAACTGAGTAAGAA ATTCAAAATGGAACTTGTTATAAATTTTTATAGCATAAGCAATAACTGGTTCTGTAATTTCCTAATCCTTCACATTAGCACAATGTGAACTAGCACCTAATTTATCTCTCCTTTGCTGTTATTAGATC ATTTGTTTTAAAGGCCTATGACTGTCTAGCTATTGTTTATAAGGTTGATTACTCAACAGGTTTGCAGTTAAGCAGTAACCACGAGGCTAACAACATATGGTTTGCTGTAAGGACTTTTAGTATTTGTC CACTGTTGGAGGCATTGATTCTTCCTGGACCCCTACAAACAGAACACTGCACTGCTCCCCTTGTGGTGGATGCCTCTTTACATACGGTCTGTGTGACATAAGTCGTGACTCTTTCCATGTCGTAGTAG TCACTAGAACTGAACAGTTGGTGTTACAAATGAGTAGAACTAGCTGGTGAGCACTCGGCTGTGCCACTGAGCACGTATATTCTCAATTGACACCATCTTAATATGGTGTGCCAACAGTGTGTGGGCAC AACTCTGCATTTAACTAATTTATCCTTACCTGGAGCTGAATAAATTATAGACAAAATTACATACTAAAGAGGAAAGCTAGTACGGGGTCAGTAAATGTCACTACACAACAAGCAGTATCATTTCCTTC TTCCCTTAGCCTTTGGGTGGGATTTGCAAATATCTCGTTTTTTAAATTAGCATTGTATTTTTTTTTTTTTTTGGTTCTTTTTTTTCGGAGCTGGGGACCGAACCCAGGGCCTTGCGCTTCCTAGGCAA GTGCTCTACCACTGAGCTAAATCCCCAACCCCTAGCATTGTATTTTTAGACGGTTTGGAGGAGTGGTTGAAGTCAGACAGGAAAGTCCAGCTTATCGGGAGTTTACCAGTACAGCGGATGAAGGAAGA GTAAGAACATCCTACACTTCAGCTCCAGAGCCAGCCGTTTTGTAGTAGTTATTAATACAGGTTCAGTATCCCTATTTCCGCTGCTCTACACCGGGAGGGCTTCAGTTTCCAGATACTGAAATGTTTGC AGACTCTACTAGTTGAGCATCCTGACTTACAAATCTGAAACCCCCCAAATTCAAAAACCTTTGAGTTCTGTGCCCTTCAGATTTCTACATTAGCGATAGTCCCATCTGTGCTTTACCCAAAGAAAAGG ATCCAGGACTATCTGCTTGTGAGAAATATAGTAGCTGTTTGTTTCTTCATTCATCACTAGTCACCAAGAACAGTTTTTCTTATTTCTCCCTTTCTGTGCTAAAAGCAAAAATTTGGAATCAGAAAACC TGAGTTTAAGTTTTAGTGTCTGTACTCTGTAGATCTGTTTGGCTGAGCAGGTGACAGTTTGTCTGAGCACTTAGTTTCTCAGTCTGGAGAGTGGACACCATAAATTCCTACTGCCTCTTTCAATGTGG CTGTGAAGATTGGGCTGTGTGACCGCTTCTGACAATCTGGAACGCCAGTGTCGTCACTTCCCACTGGTCCCGAGATAGCAAAGGAAAAAGTTGGTGTGTGAACAGACTAAAACTAAGTGCCCTGGCAG GTGAGAGAGCAGCTGCAGGTATCTTTCTGACATGTAAAATGTCCTTGAAGAAACACAGACATTAGGGGTGCCTCTGTTGTAAATGTTTATGCTTTAAACTGTCCTCACATTAGGCTAAGCACACTTAA AGAAGTTGAGGCACACGGTTAGCTGTTGAAGGTCACTGAGTAAATATGGATTTAAACCGAGGCCTTCATGTCCCTTCAACCGTCCCAGCCATTGGCAATGTACTGTATATCTGTAAGCATTTCCAGAA GACTTTCCAAACTGTCTCTGTGGTTGTTTTCATACAGCAGTTGTGAAGAGTAATTTTAAAAAACTTGTAAGAATGGATTTTTCATTTCTGCTGAGTTTGCTTGACCAGTATGTACAAGATGGAGCTAG TGTGTGTCACTAGCCCACTGTGGCTTTACTGTGTGTGTGGAAACTAACTGGAGTGACTGCTGGGTTGCTGTACCTCTGTAATCAGACTTTACAAGCCATGACATTAATTGCACTCTGTTTTCGTTGAA GCCCTATGCTGTTTAAAGAGAGACTGTAAAGGCACTGTCGTAGTTGGGAGTTGAGTAATACTCCACTGTGTAACCTGCATAACTTTTGTCATTGTCTTAAAGCCAAGCTGTGTTTGCATAAAAAGTAA TTGTTTCTTAGAAACATGTGACAATTTTCAAAGTAGTGTATAATGACACTGTTTAGTACATTTTATATTTTTTGTTACATCCCACTTTTGTAAATATTCTTAAAACTTGATAATAAAATGTATTTCTC TATCACCAT
hide sequence
RefSeq Acc Id:
XM_006239629 ⟹ XP_006239691
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 21,784,981 - 21,860,596 (+) NCBI mRatBN7.2 6 16,032,819 - 16,108,436 (+) NCBI Rnor_6.0 6 1,547,742 - 1,621,961 (-) NCBI Rnor_5.0 6 1,536,128 - 1,611,876 (-) NCBI
Sequence:
GGCGGCGGCGGGACTCGGACCCGCGCGGGGCTGGGCGGCGGCCGAAGCTGGGCGGGAAGTCGGG GCGGTGCTCCGCGAGCGGCCGGGGGCGCCGGCGCGGCCAAGTTCCGCGGTCCGCGCCGAGGCCAAGTTGGAGTCGCGCGGCTGCGGGTGACCCACCGCGCCCCAGCCCTCGGGGACCCGCTCTTTCCG AGCCCCGCAAACTAGTCCGACAGCCCGCGGCGCCGAGCGGTTGACAGCATTTCCAAAGGCACCATCTTTTCTCTCTGGGTCCATTCATCCAAAGAAATATGTTTGTGCTATTTGACAAGCTTTTTGTT TTCACCTCATCACAGGGAAGTTCAGCCACAAGATGGAAATGAGTACAGATGAGAGGGTGAATTAAGGTGTGATCATTTGTGGTGTCCCGTCAATCCCTAAAGGAATAGATTACCTGGAACTACTTTTA ATCAGGAAGATTTCATATCTTGGCACAGATTGACTATTCAATTTGTATTTTCTGAAATGCAAAGCAAAAGATAAGAACAGATTTAAAAGAAATGAAGATGTCGCATAAATAATCAGTATCAACTCTGT TCCTTTGATGATAATGGTGATGTGAAGTGGGTTACAGATCTGGGTGTGGTCCTAAAGACAAGATTCTTGATGGGACTGACATTGACAGCAGTAGGACCTTTTGTGCATTCAACTCGGAGCAACAGAAT TTGTCATCAACAGCATGAGTGGCTCAGCCAGGGAAAGAAAGCAGCTTTCATCTAAATCCAAACCATAGCCATTTTTTTTTACTGCTATTTTGAAAACTTTTCCAGAACCATTTAAAAAGCATTGACAA CTATTTTTATAGATTAAAGAAAGGCAGATGTCTGCAAATAATTCCCCTCCATCAGCCCAGAAATCTGTGTTCCCTGCAACTGTTTCTGCTGTGCTTCCAACCCCTTCTCCGTGTTCAAGTCCCAAGAC AGGACTCTCAGCTCGGCTCTCTAATGGCAGCTTCAGTGCCGCGTCACTCACAAACTCTAGAGGCTCGGTGCACACCGTTTCATTTCTACTTCAGATTGGCCTCACACGAGAGAGTGTTACCATCGAAG CCCAGGAACTGTCTCTCTCCGCTGTCAAAGACCTCGTGTGCTCCATTGTTTATCAGAAGTTTCCAGAGTGTGGATTCTTTGGCATGTATGATAAAATTCTTCTCTTTCGCCACAACATGAACTCAGAA AACATTTTGCAGCTGATTACCTCAGCAGATGAAATACATGAAGGGGATCTTGTAGAAGTTGTCCTGTCAGCTTTGGCCACAGTAGAAGACTTCCAGATCCGCCCTCATGCTCTCTATGTCCATTCTTA CAAAGCACCTACTTTCTGTGATTACTGTGGTGAAATGCTCTGGGGATTGGTACGTCAAGGATTAAAATGTGAAGGCTGTGGATTAAATTATCATAAACGATGTGCCTTCAAGATTCCAAATAACTGCA GTGGAGTAAGAAAGAGACGTCTGTCAAATGTGTCTCTGCCAGGACCTGGCCTCTCAGTTCCGAGACCCCTGCAGCCTGAATGTGTGCCCCTGCTCAGTGAAGAGTCACATACTCACCAAGAGCCAAGT AAGAGAATCCCGTCCTGGAGTGGTCGTCCGATCTGGATGGAAAAGATGGTAATGTGCAGGGTCAAAGTTCCACACACGTTTGCTGTCCACTCTTATGGCCGACCCACAATATGTCAGTACTGCAAGCG GCTGCTCAAAGGCCTCTTTCGCCAAGGACTGCAGTGTAAAGATTGCAAATTCAACTGCCACAAACGCTGTGCATCCAAAGTACCACGAGACTGCCTCGGCGAAGTTACTTTCAATGGAGAGCCTTCCA GTGTGGGAACTGATACAGACATGCCGATGGATATTGACAGTAATGATGTGAACAGTGATGGCAGTAGGGGCTTGGATGACTCAGAGGAGCCCTCCCCTCCCGAAGACAAAATGTTCTTCCTCGACGCG GCCGATCTGGATGTGGAGCGAGATGAGGAGCCGGTTAAGACAATCAGTCCATCCACAAGCAATAATATCCCACTGATGAGGGTGGTCCAGTCCATCAAGCACACAAAGAGGAAGAGCAGCACAGTGGT GAAGGAAGGGTGGATGGTCCACTACACCAGCAGGGACAACCTGAGAAAGAGACATTATTGGAGACTTGACAGCAAATGTCTAACATTGTTTCAGAATGAATCTGGATCAAAATATTATAAGGAAATTC CACTTTCAGAAATTCTCCGCATATCTTCGCCACAAGATTTCACCAGCATTTCACAAGGCAGTAACCCACACTGTTTTGAAATCATCACTGATACTGTGGTATACTTTGTTGGTGAGAACAATGGGAAC AGCACTCATAACCCTGTTCTCGCTGCCACTGGAGTGGGACTCGATGTAGCACAAAGCTGGGAAAAAGCGATCCGCCAGGCCCTCATGCCCGTTACTCCTCAAGCAAGTGTTTGCACTTCTCCAGGCCA GGGGAAGGACCACAAAGATCTGGCTACCAGTATCTCCGTGTCTAACTGTCAGATTCAGGAGAATGTAGACATCAGCAGTGTTTATCAGATCTTTGCCGATGAGGTGCTTGGTTCTGGCCAGTTTGGCA TTGTTTATGGAGGAAAGCACAGAAAGACAGGAAGGGATGTGGCTATTAAAGTAATCGATAAGATGCGATTCCCCACAAAGCAAGAGAGTCAGCTCCGGAATGAAGTGGCTATTTTACAGAATCTGCAC CATCCTGGGATTGTAAATCTGGAATGTATGTTTGAAACCCCAGAACGAGTCTTCGTAGTGATGGAAAAGCTTCATGGAGATATGTTGGAAATGATTCTGTCCAGTGAAAAAAGTCGACTTCCAGAACG GATTACTAAATTCATGGTCACACAGATACTTGTTGCCCTGAGGAATCTACATTTTAAGAATATCGTGCACTGTGATTTAAAGCCCGAAAATGTGCTGCTTGCATCTGCAGAACCTTTTCCTCAGGTGA AGCTATGTGACTTTGGGTTTGCCCGCATCATTGGTGAGAAGTCGTTCCGGAGGTCAGTGGTGGGAACTCCAGCCTACTTAGCCCCCGAGGTTCTCAGGAGCAAAGGCTACAACCGTTCCCTAGACATG TGGTCGGTGGGAGTCATAGTCTATGTGAGCCTCAGTGGCACCTTCCCGTTCAATGAAGATGAAGATATAAACGACCAAATCCAAAATGCTGCATTTATGTACCCACCAAATCCATGGCGAGAAATCTC CAGCGAAGCAATTGATTTGATAAACAACTTGCTTCAAGTGAAGATGAGAAAACGTTACAGCGTTGACAAGTCCCTCAGTCATCCCTGGCTACAGGACTATCAGACTTGGCTTGACCTCAGAGAATTCG AAACTCGCATTGGAGAACGTTACATCACACATGAAAGTGATGATGCTCGCTGGGAAATACATGCATACACGCACAATCTCGAATACCCAAAACATTTCATTATGGCCCCCAACCCGGATGACATGGAG GAAGGTCCTTAGTTGTGAGTGGGCTAATCCTATAAGGAAGGGTTTCATTTCAAGACGGATACTTTGCTGCATGACTGTTGCTCTCTGCAGACTGTCATTGCAAGGCGGCAGCATCATGAGGACATAGA AGGACGTGCTGGCATCAATTCTGTAGCTCATAACGAGTAGGTACATGAAGGGAAACTGAGTAAGAAATTCAAAATGGAACTTGTTATAAATTTTTATAGCATAAGCAATAACTGGTTCTGTAATTTCC TAATCCTTCACATTAGCACAATGTGAACTAGCACCTAATTTATCTCTCCTTTGCTGTTATTAGATCATTTGTTTTAAAGGCCTATGACTGTCTAGCTATTGTTTATAAGGTTGATTACTCAACAGGTT TGCAGTTAAGCAGTAACCACGAGGCTAACAACATATGGTTTGCTGTAAGGACTTTTAGTATTTGTCCACTGTTGGAGGCATTGATTCTTCCTGGACCCCTACAAACAGAACACTGCACTGCTCCCCTT GTGGTGGATGCCTCTTTACATACGGTCTGTGTGACATAAGTCGTGACTCTTTCCATGTCGTAGTAGTCACTAGAACTGAACAGTTGGTGTTACAAATGAGTAGAACTAGCTGGTGAGCACTCGGCTGT GCCACTGAGCACGTATATTCTCAATTGACACCATCTTAATATGGTGTGCCAACAGTGTGTGGGCACAACTCTGCATTTAACTAATTTATCCTTACCTGGAGCTGAATAAATTATAGACAAAATTACAT ACTAAAGAGGAAAGCTAGTACGGGGTCAGTAAATGTCACTACACAACAAGCAGTATCATTTCCTTCTTCCCTTAGCCTTTGGGTGGGATTTGCAAATATCTCGTTTTTTAAATTA
hide sequence
RefSeq Acc Id:
XM_006239631 ⟹ XP_006239693
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 21,806,802 - 21,860,596 (+) NCBI mRatBN7.2 6 16,063,839 - 16,108,444 (+) NCBI Rnor_6.0 6 1,547,742 - 1,591,441 (-) NCBI Rnor_5.0 6 1,536,128 - 1,611,876 (-) NCBI
Sequence:
ATGAATATACACACACACATTATCTAGGTTAAACAGTGTCAGGCAGTTATTACTAAATACTTTAACTGGAGGGAAAATTAATTTGCTGCACATTCAGATTACAATCATAGCTGAAAGAGAAAAGGTCC AGGTGTTAAAGACAATTCAGAACTAATTACAAAATAAGGGGTGAAAGTGTATTTAAAAAAGAAAAAGGATTTCTCTGGTTTATGTCAGAAGTGCAAGTGTTAGCTAAATTGAGCAACTCTGCTGGCAA GCGATATCCAGAGAACTGTGAACTAGAGACGTCGGTGAAAGGGAAGCGTCCATTCAAGTGCCTGTTGAGCCAGTCCTCACTGACTCCTCTAAACTACTGATTTTGGCCTTAAGTGAAAACAAGCATTG GAACTCTTCCCTATGGTTAAGCACTTTTCAGAGTTGGTGCTAAATTAATATTAGTCTTGTTTCTGACAATAGTCAACAGAATTTTTAATGAGTGCCAGTTAAATAACTAAGTTCTGGGCTTTTAGGGA GTCTGAGGAAACCTGGAAAGAGAACATCCTTAGCACGTGTTTTCTGTTATTTAGTATAGGTTTTAAAGACACTGTAAAGATATGCTTGGCCTTAAGTTTAAAAATCAATTTAGTATTCCATATATACT TATGTGTGTATCAACCTCTAACCAAAATCGGTGTACTTCACTTACCTATAATGAAAACAAAATTGTATGTGTTAAAACTCTAAGGGTTTCTTATTTTTATACTACCTTTTAAAAATGCCTAATGACAG GTAAATAATTCACTCAGATAGTATTGAATTCTGAAGTTGCTTGTTAACATTCAAATTGATGTATTGCCAAGTAAAATAAAAGTTTTGCAAGCTTCGTACCTTATCTGACACTTTACTAACAGAAGTTG GTGGCATGAGATTTTATGAGACAAGGCTTCAGTGTTTAGCCGCCGTTAGTCTAGAACTGGGAAAACCTTCATTTTGCACAAGGCAGAGGAACTACTGACAAAAAAAAATTTCCAGAGTGTGGATTCTT TGGCATGTATGATAAAATTCTTCTCTTTCGCCACAACATGAACTCAGAAAACATTTTGCAGCTGATTACCTCAGCAGATGAAATACATGAAGGGGATCTTGTAGAAGTTGTCCTGTCAGCTTTGGCCA CAGTAGAAGACTTCCAGATCCGCCCTCATGCTCTCTATGTCCATTCTTACAAAGCACCTACTTTCTGTGATTACTGTGGTGAAATGCTCTGGGGATTGGTACGTCAAGGATTAAAATGTGAAGGCTGT GGATTAAATTATCATAAACGATGTGCCTTCAAGATTCCAAATAACTGCAGTGGAGTAAGAAAGAGACGTCTGTCAAATGTGTCTCTGCCAGGACCTGGCCTCTCAGTTCCGAGACCCCTGCAGCCTGA ATGTGTGCCCCTGCTCAGTGAAGAGTCACATACTCACCAAGAGCCAAGTAAGAGAATCCCGTCCTGGAGTGGTCGTCCGATCTGGATGGAAAAGATGGTAATGTGCAGGGTCAAAGTTCCACACACGT TTGCTGTCCACTCTTATGGCCGACCCACAATATGTCAGTACTGCAAGCGGCTGCTCAAAGGCCTCTTTCGCCAAGGACTGCAGTGTAAAGATTGCAAATTCAACTGCCACAAACGCTGTGCATCCAAA GTACCACGAGACTGCCTCGGCGAAGTTACTTTCAATGGAGAGCCTTCCAGTGTGGGAACTGATACAGACATGCCGATGGATATTGACAGTAATGATGTGAACAGTGATGGCAGTAGGGGCTTGGATGA CTCAGAGGAGCCCTCCCCTCCCGAAGACAAAATGTTCTTCCTCGACGCGGCCGATCTGGATGTGGAGCGAGATGAGGAGCCGGTTAAGACAATCAGTCCATCCACAAGCAATAATATCCCACTGATGA GGGTGGTCCAGTCCATCAAGCACACAAAGAGGAAGAGCAGCACAGTGGTGAAGGAAGGGTGGATGGTCCACTACACCAGCAGGGACAACCTGAGAAAGAGACATTATTGGAGACTTGACAGCAAATGT CTAACATTGTTTCAGAATGAATCTGGATCAAAATATTATAAGGAAATTCCACTTTCAGAAATTCTCCGCATATCTTCGCCACAAGATTTCACCAGCATTTCACAAGGCAGTAACCCACACTGTTTTGA AATCATCACTGATACTGTGGTATACTTTGTTGGTGAGAACAATGGGAACAGCACTCATAACCCTGTTCTCGCTGCCACTGGAGTGGGACTCGATGTAGCACAAAGCTGGGAAAAAGCGATCCGCCAGG CCCTCATGCCCGTTACTCCTCAAGCAAGTGTTTGCACTTCTCCAGGCCAGGGGAAGGACCACAAAGATCTGGCTACCAGTATCTCCGTGTCTAACTGTCAGATTCAGGAGAATGTAGACATCAGCAGT GTTTATCAGATCTTTGCCGATGAGGTGCTTGGTTCTGGCCAGTTTGGCATTGTTTATGGAGGAAAGCACAGAAAGACAGGAAGGGATGTGGCTATTAAAGTAATCGATAAGATGCGATTCCCCACAAA GCAAGAGAGTCAGCTCCGGAATGAAGTGGCTATTTTACAGAATCTGCACCATCCTGGGATTGTAAATCTGGAATGTATGTTTGAAACCCCAGAACGAGTCTTCGTAGTGATGGAAAAGCTTCATGGAG ATATGTTGGAAATGATTCTGTCCAGTGAAAAAAGTCGACTTCCAGAACGGATTACTAAATTCATGGTCACACAGATACTTGTTGCCCTGAGGAATCTACATTTTAAGAATATCGTGCACTGTGATTTA AAGCCCGAAAATGTGCTGCTTGCATCTGCAGAACCTTTTCCTCAGGTGAAGCTATGTGACTTTGGGTTTGCCCGCATCATTGGTGAGAAGTCGTTCCGGAGGTCAGTGGTGGGAACTCCAGCCTACTT AGCCCCCGAGGTTCTCAGGAGCAAAGGCTACAACCGTTCCCTAGACATGTGGTCGGTGGGAGTCATAGTCTATGTGAGCCTCAGTGGCACCTTCCCGTTCAATGAAGATGAAGATATAAACGACCAAA TCCAAAATGCTGCATTTATGTACCCACCAAATCCATGGCGAGAAATCTCCAGCGAAGCAATTGATTTGATAAACAACTTGCTTCAAGTGAAGATGAGAAAACGTTACAGCGTTGACAAGTCCCTCAGT CATCCCTGGCTACAGGACTATCAGACTTGGCTTGACCTCAGAGAATTCGAAACTCGCATTGGAGAACGTTACATCACACATGAAAGTGATGATGCTCGCTGGGAAATACATGCATACACGCACAATCT CGAATACCCAAAACATTTCATTATGGCCCCCAACCCGGATGACATGGAGGAAGGTCCTTAGTTGTGAGTGGGCTAATCCTATAAGGAAGGGTTTCATTTCAAGACGGATACTTTGCTGCATGACTGTT GCTCTCTGCAGACTGTCATTGCAAGGCGGCAGCATCATGAGGACATAGAAGGACGTGCTGGCATCAATTCTGTAGCTCATAACGAGTAGGTACATGAAGGGAAACTGAGTAAGAAATTCAAAATGGAA CTTGTTATAAATTTTTATAGCATAAGCAATAACTGGTTCTGTAATTTCCTAATCCTTCACATTAGCACAATGTGAACTAGCACCTAATTTATCTCTCCTTTGCTGTTATTAGATCATTTGTTTTAAAG GCCTATGACTGTCTAGCTATTGTTTATAAGGTTGATTACTCAACAGGTTTGCAGTTAAGCAGTAACCACGAGGCTAACAACATATGGTTTGCTGTAAGGACTTTTAGTATTTGTCCACTGTTGGAGGC ATTGATTCTTCCTGGACCCCTACAAACAGAACACTGCACTGCTCCCCTTGTGGTGGATGCCTCTTTACATACGGTCTGTGTGACATAAGTCGTGACTCTTTCCATGTCGTAGTAGTCACTAGAACTGA ACAGTTGGTGTTACAAATGAGTAGAACTAGCTGGTGAGCACTCGGCTGTGCCACTGAGCACGTATATTCTCAATTGACACCATCTTAATATGGTGTGCCAACAGTGTGTGGGCACAACTCTGCATTTA ACTAATTTATCCTTACCTGGAGCTGAATAAATTATAGACAAAATTACATACTAAAGAGGAAAGCTAGTACGGGGTCAGTAAATGTCACTACACAACAAGCAGTATCATTTCCTTCTTCCCTTAGCCTT TGGGTGGGATTTGCAAATATCTCGTTTTTTAAATTA
hide sequence
RefSeq Acc Id:
XM_039112128 ⟹ XP_038968056
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 21,784,696 - 21,860,596 (+) NCBI mRatBN7.2 6 16,032,552 - 16,108,444 (+) NCBI
RefSeq Acc Id:
XM_039112129 ⟹ XP_038968057
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 21,784,665 - 21,860,596 (+) NCBI mRatBN7.2 6 16,032,507 - 16,108,444 (+) NCBI
RefSeq Acc Id:
XM_063261804 ⟹ XP_063117874
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 21,784,988 - 21,860,596 (+) NCBI
RefSeq Acc Id:
NP_001019434 ⟸ NM_001024263
- UniProtKB:
D4A229 (UniProtKB/TrEMBL), A0A8I6G5U2 (UniProtKB/TrEMBL)
- Sequence:
MSANNSPPSAQKSVFPATVSAVLPTPSPCSSPKTGLSARLSNGSFSAASLTNSRGSVHTVSFLLQIGLTRESVTIEAQELSLSAVKDLVCSIVYQKFPECGFFGMYDKILLFRHNMNSENILQLITSA DEIHEGDLVEVVLSALATVEDFQIRPHALYVHSYKAPTFCDYCGEMLWGLVRQGLKCEGCGLNYHKRCAFKIPNNCSGVRKRRLSNVSLPGPGLSVPRPLQPECVPLLSEESHTHQEPSKRIPSWSGR PIWMEKMVMCRVKVPHTFAVHSYGRPTICQYCKRLLKGLFRQGLQCKDCKFNCHKRCASKVPRDCLGEVTFNGEPSSVGTDTDMPMDIDSNDVNSDGSRGLDDSEEPSPPEDKMFFLDAADLDVERDE EPVKTISPSTSNNIPLMRVVQSIKHTKRKSSTVVKEGWMVHYTSRDNLRKRHYWRLDSKCLTLFQNESGSKYYKEIPLSEILRISSPQDFTSISQGSNPHCFEIITDTVVYFVGENNGNSTHNPVLAA TGVGLDVAQSWEKAIRQALMPVTPQASVCTSPGQGKDHKDLATSISVSNCQIQENVDISSVYQIFADEVLGSGQFGIVYGGKHRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLEC MFETPERVFVVMEKLHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIVYV SLSGTFPFNEDEDINDQIQNAAFMYPPNPWREISSEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLREFETRIGERYITHESDDARWEIHAYTHNLEYPKHFIMAPNPDDMEEGP
hide sequence
RefSeq Acc Id:
XP_006239691 ⟸ XM_006239629
- Peptide Label:
isoform X1
- UniProtKB:
D4A229 (UniProtKB/TrEMBL), A0A8I6G5U2 (UniProtKB/TrEMBL)
- Sequence:
MSANNSPPSAQKSVFPATVSAVLPTPSPCSSPKTGLSARLSNGSFSAASLTNSRGSVHTVSFLLQIGLTRESVTIEAQELSLSAVKDLVCSIVYQKFPECGFFGMYDKILLFRHNMNSENILQLITSA DEIHEGDLVEVVLSALATVEDFQIRPHALYVHSYKAPTFCDYCGEMLWGLVRQGLKCEGCGLNYHKRCAFKIPNNCSGVRKRRLSNVSLPGPGLSVPRPLQPECVPLLSEESHTHQEPSKRIPSWSGR PIWMEKMVMCRVKVPHTFAVHSYGRPTICQYCKRLLKGLFRQGLQCKDCKFNCHKRCASKVPRDCLGEVTFNGEPSSVGTDTDMPMDIDSNDVNSDGSRGLDDSEEPSPPEDKMFFLDAADLDVERDE EPVKTISPSTSNNIPLMRVVQSIKHTKRKSSTVVKEGWMVHYTSRDNLRKRHYWRLDSKCLTLFQNESGSKYYKEIPLSEILRISSPQDFTSISQGSNPHCFEIITDTVVYFVGENNGNSTHNPVLAA TGVGLDVAQSWEKAIRQALMPVTPQASVCTSPGQGKDHKDLATSISVSNCQIQENVDISSVYQIFADEVLGSGQFGIVYGGKHRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLEC MFETPERVFVVMEKLHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIVYV SLSGTFPFNEDEDINDQIQNAAFMYPPNPWREISSEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLREFETRIGERYITHESDDARWEIHAYTHNLEYPKHFIMAPNPDDMEEGP
hide sequence
RefSeq Acc Id:
XP_006239693 ⟸ XM_006239631
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6G5U2 (UniProtKB/TrEMBL)
- Sequence:
MYDKILLFRHNMNSENILQLITSADEIHEGDLVEVVLSALATVEDFQIRPHALYVHSYKAPTFCDYCGEMLWGLVRQGLKCEGCGLNYHKRCAFKIPNNCSGVRKRRLSNVSLPGPGLSVPRPLQPEC VPLLSEESHTHQEPSKRIPSWSGRPIWMEKMVMCRVKVPHTFAVHSYGRPTICQYCKRLLKGLFRQGLQCKDCKFNCHKRCASKVPRDCLGEVTFNGEPSSVGTDTDMPMDIDSNDVNSDGSRGLDDS EEPSPPEDKMFFLDAADLDVERDEEPVKTISPSTSNNIPLMRVVQSIKHTKRKSSTVVKEGWMVHYTSRDNLRKRHYWRLDSKCLTLFQNESGSKYYKEIPLSEILRISSPQDFTSISQGSNPHCFEI ITDTVVYFVGENNGNSTHNPVLAATGVGLDVAQSWEKAIRQALMPVTPQASVCTSPGQGKDHKDLATSISVSNCQIQENVDISSVYQIFADEVLGSGQFGIVYGGKHRKTGRDVAIKVIDKMRFPTKQ ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLA PEVLRSKGYNRSLDMWSVGVIVYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWREISSEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLREFETRIGERYITHESDDARWEIHAYTHNLE YPKHFIMAPNPDDMEEGP
hide sequence
Ensembl Acc Id:
ENSRNOP00000069846 ⟸ ENSRNOT00000084528
Ensembl Acc Id:
ENSRNOP00000007491 ⟸ ENSRNOT00000007492
RefSeq Acc Id:
XP_038968057 ⟸ XM_039112129
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6G5U2 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038968056 ⟸ XM_039112128
- Peptide Label:
isoform X1
- UniProtKB:
D4A229 (UniProtKB/TrEMBL), A0A8I6G5U2 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000077406 ⟸ ENSRNOT00000101507
Ensembl Acc Id:
ENSRNOP00000079860 ⟸ ENSRNOT00000095865
RefSeq Acc Id:
XP_063117874 ⟸ XM_063261804
- Peptide Label:
isoform X1
- UniProtKB:
D4A229 (UniProtKB/TrEMBL), A0A8I6G5U2 (UniProtKB/TrEMBL)
RGD ID: 13694361
Promoter ID: EPDNEW_R4882
Type: initiation region
Name: Prkd3_2
Description: protein kinase D3
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_R4883
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 6 1,583,411 - 1,583,471 EPDNEW
RGD ID: 13694358
Promoter ID: EPDNEW_R4883
Type: initiation region
Name: Prkd3_1
Description: protein kinase D3
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_R4882
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 6 1,622,252 - 1,622,312 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-03-17
Prkd3
protein kinase D3
Prkcn
protein kinase C, nu
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-12-06
Prkcn
protein kinase C, nu
Prkcn_predicted
protein kinase C, nu (predicted)
Symbol and Name updated
1559027
APPROVED
2005-01-12
Prkcn_predicted
protein kinase C, nu (predicted)
Symbol and Name status set to approved
70820
APPROVED